Sexual Dysfunction Male Clinical Trial
Official title:
Effects of Lepidium Meyenii (Maca) Extract Supplementation on Male Sexual Funtion
The purpose of this study was to investigate the effects of Lepidium meyenii (Maca) extract supplementation on male sexual funtion.
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | May 2024 |
Est. primary completion date | April 2024 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: 1. evaluated as sexual dysfunction for more than three months by physician 2. international index of erectile function (IIEF) score is less than or equal to 21 3. erectile hardness score (EHS) score is less than or equal to 3 4. aged over 18 years old Exclusion Criteria: 1. unable to cooperate with the course of the treatment 2. suffering from sexually transmitted diseases such as Syphilis, AIDS and HPVs 3. had Radical Prostatectomy (total removal of the prostate gland) 4. suffering from active tumors in the prostate or pelvic area 5. suffering from Hypogonadism 6. anatomical deformation of the penis 7. men with penile prosthesis 8. suffering from psychotic disorder (manic disorder, chronic depression, etc.) 9. suffering from neurological diseases (multiple sclerosis, brain or spinal cord injuries, etc.) 10. using Permanent pacemaker 11. considered unsuitable to participate in this experiment according to the doctor 12. alcohol or drug abuse |
Country | Name | City | State |
---|---|---|---|
Taiwan | Taipei Medical University | Taipei |
Lead Sponsor | Collaborator |
---|---|
Taipei Medical University |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | IIEF-5 score | Baseline (before supplementation) | ||
Primary | IIEF-5 score | 6 weeks of supplementation | ||
Primary | IIEF-5 score | 12 weeks of supplementation | ||
Primary | IIEF-5 score | 18 weeks of supplementation | ||
Primary | IIEF-5 score | 24 weeks of supplementation | ||
Primary | EHS score | Baseline (before supplementation) | ||
Primary | EHS score | 6 weeks of supplementation | ||
Primary | EHS score | 12 weeks of supplementation | ||
Primary | EHS score | 18 weeks of supplementation | ||
Primary | EHS score | 24 weeks of supplementation | ||
Primary | level of PSA | Baseline (before supplementation) | ||
Primary | level of PSA | 6 weeks of supplementation | ||
Primary | level of PSA | 12 weeks of supplementation | ||
Primary | level of PSA | 18 weeks of supplementation | ||
Primary | level of PSA | 24 weeks of supplementation | ||
Primary | Testosterone level | Baseline (before supplementation) | ||
Primary | Testosterone level | 6 weeks of supplementation | ||
Primary | Testosterone level | 12 weeks of supplementation | ||
Primary | Testosterone level | 18 weeks of supplementation | ||
Primary | Testosterone level | 24 weeks of supplementation | ||
Primary | LH level | Baseline (before supplementation) | ||
Primary | LH level | 6 weeks of supplementation | ||
Primary | LH level | 12 weeks of supplementation | ||
Primary | LH level | 18 weeks of supplementation | ||
Primary | LH level | 24 weeks of supplementation | ||
Primary | Level of FSH | Baseline (before supplementation) | ||
Primary | Level of FSH | 6 weeks of supplementation | ||
Primary | Level of FSH | 12 weeks of supplementation | ||
Primary | Level of FSH | 18 weeks of supplementation | ||
Primary | Level of FSH | 24 weeks of supplementation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04512287 -
PRP for Treatment of Peyronie's Disease
|
Phase 2 | |
Not yet recruiting |
NCT05960682 -
French Translation and Validation of the Brief Index of Sexual Functioning for Men
|
||
Completed |
NCT03365518 -
Innovations in the Treatment of Sexual Health Post Prostate Cancer Treatment: Comparing Mindfulness vs. CBT
|
N/A | |
Recruiting |
NCT05345418 -
Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency
|
Phase 1/Phase 2 |